Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:ceo |
gptkb:Daniel_O'_Connor
|
| gptkbp:clinical_trial |
gptkb:KEYNOTE-890
|
| gptkbp:develops |
electroporation technology
|
| gptkbp:focuses_on |
cancer immunotherapy
|
| gptkbp:founded |
gptkb:2012
|
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Onco Sec Medical
|
| gptkbp:partnership |
gptkb:Merck_&_Co.
|
| gptkbp:technology |
TAVO
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:Ariad_Pharmaceuticals
|
| gptkbp:bfsLayer |
4
|